Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease-Reference-Cited by-同舟云学术

Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease

Published:2013-01 Issue: Volume:415 Page:138-144
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Yeh Yuan-Hung,Wang Po-Hui,Lin Long-Yau,Tee Yi-Torng,Chou Ming-Chih,Yang Shun-Fa,Tsai Hsiu-Ting

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference37 articles.

1. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity;Latthe;BMC Public Health,2006

2. Prevalence of cervical infection by Chlamydia trachomatis among Chilean women living in the Metropolitan region;Martinez;Rev Med Chil,2008

3. Chlamydia screening among sexually active young female enrollees of health plans—United States, 2000–2007;MMWR Morb Mortal Wkly Rep,2009

4. A review on infection with Chlamydia trachomatis;Manavi;Best Pract Res Clin Obstet Gynaecol,2006

5. Pelvic inflammatory disease in adolescents;Gray-Swain;Curr Opin Obstet Gynecol,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional activation and regulation of urokinase plasminogen activator inducted by LPS through MyD88 independent pathway in rat Sertoli cells;Folia Histochemica et Cytobiologica;2021-12-23

2. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study;Journal of Endocrinological Investigation;2020-07-17

3. Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia;International Journal of Environmental Research and Public Health;2019-03-21

4. Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytes;Genetics and Molecular Research;2015

5. The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease;Journal of Investigative Medicine;2014-10